Clinical Trials Arena
Cellectis to focus on CAR-T cell therapies in 2023
Cellectis has provided an update on three clinical trials AMELI-01, BALLI-01 and NATHALI-01 evaluating its three chimeric antigen receptor (CAR)…
Addex wins $3m to research substance use therapy
Addex Therapeutics and Indivior have extended their research agreement for the drug discovery of novel oral gamma-aminobutyric acid subtype B…
Closure of the National Cancer Research Institute: UK cancer research landscape takes a hit
In June 2023, a closure announcement from the National Cancer Research Institute (NCRI) shook the UK cancer community. The charity…
UK Government faces an uphill battle to restore clinical trials in the country
Aside from evaluating the safety and efficacy of a drug or device, clinical trials play other crucial roles. Lord O’Shaughnessy’s…
Vivoryon issues updates on its Alzheimer’s therapy programme
Netherlands-based Vivoryon Therapeutics has provided updates on its clinical development programme for varoglutamstat for treating Alzheimer’s disease (AD), including clinical…